From: Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis
20 years horizon
Mean value
95% CI
Life years gained
1.0
0.7 – 1.4
DALY averted
3.7
2.9 – 4.5
70 years horizon
4.1
3.0 – 5.7
6.0
4.7 – 7.5